Life sciences companies face a multitude of changing global transparency reporting regulations, including the expansion of CMS’ Open Payments program which includes a wide range of new covered recipients, as well as updates to European guidelines around payment disclosures. Is your organization ready to adapt and navigate the new requirements successfully?
Listen as MediSpend’s Chief Commercial Officer, Seth Houston, Guidehouse’s Partner and Global Leader of Life Sciences Governance, Risk Management and Compliance, Mark Farrar, and Guidehouse’s Managing Consultant, Matt Chandler, review the new regulations, guidelines and discuss how to prepare for on-time compliant reporting.
To learn more, please provide us your information to access the webinar “Navigating New Compliance Regulations in the Life Sciences Industry.” In this webinar, Seth, Mark and Matt discuss the upcoming regulation changes for 2021, privacy implications as they relate to GDPR, how technology can help your organization adapt faster and provide actionable next steps for your organization to prepare for these changes.
About MediSpend
MediSpend is a global technology company providing best-in-class solutions that enable life science companies to compliantly manage high-risk business functions through top-rated software and client services. MediSpend is the compliance system of record for some of the world’s largest pharmaceutical, medical device, dental and emerging biotech companies around the world. The MediSpend Global Compliance Suite represents the industry’s first global SaaS solution purpose-built to manage the end-to-end process of HCP engagement through transparency reporting, which includes software that facilitates external grant requests. MediSpend is headquartered in Portsmouth, N.H., with offices in Minnesota, New York, Pennsylvania and the Netherlands.